Report Detail
Global (United States, European Union and China) Candesartan Cilexetil Drug Market Research Report 2019-2025
- RnM3666030 |
- 13 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Candesartan cilexetil (candesartan) is a drug used for treating high blood pressure (hypertension). It is in a class of drugs called angiotensin receptor blockers (ARBs) which includes losartan (Cozaar), valsartan (Diovan), and irbesartan (Avapro). Angiotensin, formed in the blood by the action of angiotensin converting enzyme (ACE), is a powerful chemical that attaches to angiotensin receptors found in many tissues but primarily on smooth muscle cells surrounding blood vessels. Angiotensin's attachment to the receptors causes the muscle cells to contract and the blood vessels to narrow (vasoconstrict) which leads to an increase in blood pressure. Candesartan blocks the angiotensin receptor and therby prevents the action of angiotensin. As a result blood vessels expand and blood pressure is reduced. Candesartan was approved by the FDA in 1998.
In 2019, the market size of Candesartan Cilexetil Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Candesartan Cilexetil Drug.
This report studies the global market size of Candesartan Cilexetil Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Candesartan Cilexetil Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AstraZeneca
ANI Pharmaceuticals
Mylan
Zydus Pharmaceuticals
MACLEODS
Alembic Pharmaceuticals
Teva
LUPIN
Sun Pharmaceutical
Chongqing Shenghuaxi Pharma
Market Segment by Product Type
4 mg Tablets
8 mg Tablets
16 mg Tablets
32 mg Tablets
Market Segment by Application
Essential hypertension in adults
Hypertension in children and adolescents aged 6 to < 18 years
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Candesartan Cilexetil Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Candesartan Cilexetil Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Candesartan Cilexetil Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Candesartan Cilexetil Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 4 mg Tablets
- 1.3.3 8 mg Tablets
- 1.3.4 16 mg Tablets
- 1.3.5 32 mg Tablets
- 1.4 Market Segment by Application
- 1.4.1 Global Candesartan Cilexetil Drug Market Share by Application (2019-2025)
- 1.4.2 Essential hypertension in adults
- 1.4.3 Hypertension in children and adolescents aged 6 to < 18 years
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Candesartan Cilexetil Drug Market Size
- 2.1.1 Global Candesartan Cilexetil Drug Revenue 2014-2025
- 2.1.2 Global Candesartan Cilexetil Drug Sales 2014-2025
- 2.2 Candesartan Cilexetil Drug Growth Rate by Regions
- 2.2.1 Global Candesartan Cilexetil Drug Sales by Regions 2014-2019
- 2.2.2 Global Candesartan Cilexetil Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Candesartan Cilexetil Drug Sales by Manufacturers
- 3.1.1 Candesartan Cilexetil Drug Sales by Manufacturers 2014-2019
- 3.1.2 Candesartan Cilexetil Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Candesartan Cilexetil Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Candesartan Cilexetil Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Candesartan Cilexetil Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Candesartan Cilexetil Drug Price by Manufacturers
- 3.4 Key Manufacturers Candesartan Cilexetil Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Candesartan Cilexetil Drug Market
- 3.6 Key Manufacturers Candesartan Cilexetil Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 4 mg Tablets Sales and Revenue (2014-2019)
- 4.1.2 8 mg Tablets Sales and Revenue (2014-2019)
- 4.1.3 16 mg Tablets Sales and Revenue (2014-2019)
- 4.1.4 32 mg Tablets Sales and Revenue (2014-2019)
- 4.2 Global Candesartan Cilexetil Drug Sales Market Share by Type
- 4.3 Global Candesartan Cilexetil Drug Revenue Market Share by Type
- 4.4 Candesartan Cilexetil Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Candesartan Cilexetil Drug Sales by Application
6 United States
- 6.1 United States Candesartan Cilexetil Drug Breakdown Data by Company
- 6.2 United States Candesartan Cilexetil Drug Breakdown Data by Type
- 6.3 United States Candesartan Cilexetil Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Candesartan Cilexetil Drug Breakdown Data by Company
- 7.2 European Union Candesartan Cilexetil Drug Breakdown Data by Type
- 7.3 European Union Candesartan Cilexetil Drug Breakdown Data by Application
8 China
- 8.1 China Candesartan Cilexetil Drug Breakdown Data by Company
- 8.2 China Candesartan Cilexetil Drug Breakdown Data by Type
- 8.3 China Candesartan Cilexetil Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Candesartan Cilexetil Drug Breakdown Data by Company
- 9.2 Rest of World Candesartan Cilexetil Drug Breakdown Data by Type
- 9.3 Rest of World Candesartan Cilexetil Drug Breakdown Data by Application
- 9.4 Rest of World Candesartan Cilexetil Drug Breakdown Data by Countries
- 9.4.1 Rest of World Candesartan Cilexetil Drug Sales by Countries
- 9.4.2 Rest of World Candesartan Cilexetil Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AstraZeneca
- 10.1.1 AstraZeneca Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.1.4 Candesartan Cilexetil Drug Product Introduction
- 10.1.5 AstraZeneca Recent Development
- 10.2 ANI Pharmaceuticals
- 10.2.1 ANI Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.2.4 Candesartan Cilexetil Drug Product Introduction
- 10.2.5 ANI Pharmaceuticals Recent Development
- 10.3 Mylan
- 10.3.1 Mylan Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.3.4 Candesartan Cilexetil Drug Product Introduction
- 10.3.5 Mylan Recent Development
- 10.4 Zydus Pharmaceuticals
- 10.4.1 Zydus Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.4.4 Candesartan Cilexetil Drug Product Introduction
- 10.4.5 Zydus Pharmaceuticals Recent Development
- 10.5 MACLEODS
- 10.5.1 MACLEODS Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.5.4 Candesartan Cilexetil Drug Product Introduction
- 10.5.5 MACLEODS Recent Development
- 10.6 Alembic Pharmaceuticals
- 10.6.1 Alembic Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.6.4 Candesartan Cilexetil Drug Product Introduction
- 10.6.5 Alembic Pharmaceuticals Recent Development
- 10.7 Teva
- 10.7.1 Teva Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.7.4 Candesartan Cilexetil Drug Product Introduction
- 10.7.5 Teva Recent Development
- 10.8 LUPIN
- 10.8.1 LUPIN Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.8.4 Candesartan Cilexetil Drug Product Introduction
- 10.8.5 LUPIN Recent Development
- 10.9 Sun Pharmaceutical
- 10.9.1 Sun Pharmaceutical Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.9.4 Candesartan Cilexetil Drug Product Introduction
- 10.9.5 Sun Pharmaceutical Recent Development
- 10.10 Chongqing Shenghuaxi Pharma
- 10.10.1 Chongqing Shenghuaxi Pharma Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Candesartan Cilexetil Drug
- 10.10.4 Candesartan Cilexetil Drug Product Introduction
- 10.10.5 Chongqing Shenghuaxi Pharma Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Candesartan Cilexetil Drug Sales Channels
- 11.2.2 Candesartan Cilexetil Drug Distributors
- 11.3 Candesartan Cilexetil Drug Customers
12 Market Forecast
- 12.1 Global Candesartan Cilexetil Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Candesartan Cilexetil Drug Sales Forecast by Type
- 12.3 Global Candesartan Cilexetil Drug Sales Forecast by Application
- 12.4 Candesartan Cilexetil Drug Forecast by Regions
- 12.4.1 Global Candesartan Cilexetil Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Candesartan Cilexetil Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on CandesartanCilexetilDrug. Industry analysis & Market Report on CandesartanCilexetilDrug is a syndicated market report, published as Global (United States, European Union and China) Candesartan Cilexetil Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of CandesartanCilexetilDrug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
